# At Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/at-co

- Industry: Medical Devices & Equipment
- Headquarters: Osaka-shi, Japan
- Website: www.kekkan-bijin.jp/
- Total disclosed funding: $0.4M
- Latest round: Series A (Jul 5, 2021)
- Investors on record: 1

## About

Based in Japan, At Co., Ltd. specializes in innovative healthcare solutions, primarily focusing on capillary analysis technology to enhance health monitoring and preventive care for varied users.Established in 2009 and headquartered in Osaka-shi, Japan, At Co., Ltd. develops healthcare solutions leveraging capillary analysis. The company has executed 2 deals, with its most recent deal on July 5, 2021. In this funding, it raised JPY 42.000 mn through a Series A round led by MIRAIDOOR, bringing its total funding to JPY 42.000 mn and current valuation to JPY 988.235 mn. The company was founded by Andrew Titaley, who has a history in entrepreneurship.At Co., Ltd. specializes in developing and selling healthcare solutions centered around capillary analysis technology. Their flagship product, the?????????????? (Capillary Scope "Vascular Beauty"), enables non-invasive observation of capillary blood flow, assessing critical parameters such as capillary twisting, thickness, and cloudiness in blood flow. Their client base includes pharmacies, research institutions, healthcare professionals, and consumers focused on health monitoring. The company is expanding its market reach beyond Japan to other regions demanding healthcare and wellness technology for preventive care.The revenue model for At Co., Ltd. is primarily based on direct sales of their products, including the?????????????? and capillary image analysis software, CAS. Their clientele encompasses pharmacies, fitness facilities, wellness centers, and academic institutions. The company engages in business-to-business transactions, supplying technology for customer counseling and health assessments, with their pricing structure tailored to accommodate both consumers and institutional clients while emphasizing accessibility for various users.Following the recent funding round in July 2021, At Co., Ltd. plans to leverage the JPY 42.000 mn raised to enhance product development and market expansion. The company is focused on designing new healthcare products and extending its reach into international markets where healthcare technology is needed. Specific target regions for expansion will be identified to facilitate health checks and preventive care initiatives.

## Funding rounds

- Series A, Jul 5, 2021, $0.4M — MIRAIDOOR

## Investors

- MIRAIDOOR (https://capitalatlas.ai/funds/miraidoor) — Series A